Cardiology General
Jun 14, 2010
Peripheral arterial disease (PAD) is a highly prevalent but largely undiagnosed condition that affects an estimated 27 million people in Europe and North America. Caused by atherosclerotic occlusion o...
Jun 01, 2010
An estimated 6 million people undergo non-cardiac surgery each year, and up to a quarter of these procedures (eg, major intra-abdominal, thoracic vascular, and orthopedic procedures) are associated wi...
Jun 01, 2010
Metabolic syndrome is characterized by interrelated risk factors for cardiovascular disease (CVD) and diabetes, including dysglycemia, hypertension, raised triglyceride levels, low HDL cholesterol lev...
May 17, 2010
Pulmonary arterial hypertension (PAH) is a complex, multidisciplinary disorder resulting from restricted flow through the pulmonary arterial circulation; this results in increased pulmonary vascular r...
May 17, 2010
Research has shown that when compared with moderate-dose statins, intensive statin therapy can reduce major adverse cardiac events among patients with acute coronary syndrome (ACS). However, the resul...
May 03, 2010
Hypertension affects approximately 70 million Americans and is a major risk factor for cardiovascular disease. It has been estimated that up to 65% of patients with hypertension do not have their bloo...
Apr 05, 2010
The American College of Cardiology (ACC) held its 2010 annual scientific sessions from March 14 to 16 in Atlanta. The features below highlight some of the news emerging from the ACC scientific session...
Mar 01, 2010
The American Heart Association held its 2009 Scientific Sessions from November 14 to 18 in Orlando. The features below highlight some of the news emerging from the meeting. For more information on the...
Feb 08, 2010
The International Symposium on Endovascular Therapy, or ISET, held its 2010 annual meeting from January 17-21in Hollywood, Florida. The features below highlight some of the news emerging from the meet...
Jan 25, 2010
Data presented at Renal Week 2009 demonstrate that an angiotensin receptor blocker—olmesartan—appears to provide vascular protection in patients with type 2 diabetes by controlling blood pressure ...
Jan 11, 2010
New research presented at CHEST 2009, the annual international scientific assembly of the American College of Chest Physicians, from October 31 to November 5 in San Diego addressed key issues in the f...